175
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Tacrolimus as second-line therapy in acute severe autoimmune hepatitis

Page 298 | Received 08 Dec 2020, Accepted 18 Dec 2020, Published online: 28 Dec 2020

References

  • Rahim MN, Liberal R, Miquel R, et al. Acute severe autoimmune hepatitis: corticosteroids or liver transplantation? Liver Transpl. 2019;25(6):946–959.
  • Roberts SK, Strasser SI, Nicoll AJ, et al. Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis. Scand J Gastroenterol. 2020;55(11):1309–1317.
  • Efe C, Hagstrom H, Ytting H, et al. Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2017;15(12):1950–1956 e1.
  • Efe C, Taii HA, Ytting H, Aehling N, et al. Tacrolimus and mycophenolate mofetil as second-line therapies for pediatric patients with autoimmune hepatitis. Dig Dis Sci. 2018;63(5):1348–1354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.